Commonwealth Equity Services’s ADC Therapeutics ADCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$66.6K Sell
17,769
-40
-0.2% -$158 ﹤0.01% 4177
2025
Q4
$62.9K Sell
17,809
-5,001
-22% -$20.3K ﹤0.01% 4160
2025
Q3
$91K Sell
22,810
-1,767
-7% -$5.57K ﹤0.01% 4101
2025
Q2
$66K Sell
24,577
-14,734
-37% -$31K ﹤0.01% 4129
2025
Q1
$55K Sell
39,311
-300
-0.8% -$510 ﹤0.01% 4055
2024
Q4
$79K Sell
39,611
-802
-2% -$2.1K ﹤0.01% 3938
2024
Q3
$127K Buy
40,413
+7,813
+24% +$24.6K ﹤0.01% 3824
2024
Q2
$103K Buy
32,600
+13,783
+73% +$54.8K ﹤0.01% 3806
2024
Q1
$84K Sell
18,817
-1,035
-5% -$3.82K ﹤0.01% 3827
2023
Q4
$33K Buy
+19,852
New +$18.3K ﹤0.01% 3790
2023
Q2
Sell
-10,093
Closed -$19 3832
2023
Q1
$19 Buy
+10,093
New +$37.2K ﹤0.01% 3673

Other funds holding ADCT